Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region

By H. Mehanna, T. Beech, T. Nicholson, I. El-Hariry, C. McConkey, V. Paleri, S. Roberts. Head and Neck, 2013

817 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Otorhinolaryngology

View Paper: https://www.semanticscholar.org/paper/e6bdc31eaa34d8c702654464fbaea3ebb9baacdc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Christian Kranjec
2. H. Griffin
3. Nagayasu Egawa
4. I. Murakami
5. J. Doorbar

Citations in the corpus

• Oral cavity and oropharyngeal squamous cell carcinoma—an update (2015, background): “In addition, recent data suggest that the HPV-positive fraction of OP-SCC in Europe is increasing at an especially rapid rate and, thus, may be approaching that of North America.(75) The risk profile for HPV-positive oropharyngeal carcinomas differs from that for HPV-negative tumors.”
• Human papillomavirus molecular biology and disease association (2015, background): “A recent meta-analysis showed that HPV prevalence in HNSCC increased significantly from 41% in 2000 to 72% in 2004 [57].”
• Oral diseases: a global public health challenge. (2019, background): “In many high-income countries human papilloma virus (HPV) infection is 205 responsible for a steep rise in incidence of oro-pharyngeal cancers among young 206 people.(28) Rates of oral cancers are greater among men, older age-groups, and those 207 from poorer backgrounds – with socioeconomic inequal”